Differential expression of matrix metalloproteinases 2 and 9 by glial Müller cells: Response to soluble and extracellular matrix-bound tumor necrosis factor-α

American Journal of Pathology

Volumn 160, Issue 5, 2002, Pages 1847-1855

  Limb, G Astrid ^a   Daniels, Julie T ^a   Pleass, Robert ^a   Charteris, David G ^a   Luthert, Philip J ^a   Khaw, Peng T ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FIBRONECTIN; GELATINASE A; GELATINASE B; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ARTICLE; CELL CULTURE; CELL FUNCTION; CELL INTERACTION; CELL LEVEL; CELL MIGRATION; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; GLIA CELL; GLIOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MUELLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA DISEASE; WOUND HEALING;

EID: 0036095185     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61131-5     Document Type: Article

References (60)

1. The Müller cell: A functional element of the retina
2. Müller cells in detached human retina express glial fibrillary acidic protein and vimentin
3. Müller cell changes in human diabetic retinopathy
4. Intermediate filament expression in human retinal macroglia: Histopathologic changes associated with age-related macular degeneration
5. Histopathology and immunohistochemistry of the neurosensory retina in fundus flavimaculatus
6. Matrix and the retinal pigment epithelium in proliferative retinal disease
7. Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy
8. Limiting the proliferation and reactivity of retinal Müller cells during experimental retinal detachment: The value of oxygen supplementation
9. Cellular response in subretinal neovascularization induced by bFGF-impregnated microspheres
10. Membrane-type matrix metalloproteinases
11. Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation
12. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase= gelatinase A) by malignant glioma cell lines: Implications for the growth and cellular invasion of the extracellular matrix
13. Matrix metalloproteinase-9 over-expression enhances smooth muscle cell migration and alters remodelling in the injured rat carotid artery
14. Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation
15. Autocrine production of matrix metalloproteinase-2 is required for human airway smooth muscle proliferation
16. A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy
17. Matrix metalloproteinases and their inhibitors in human vitreous
18. Predominance of MMP-1 and MMP-2 in epiretinal membranes of proliferative vitreoretinopathy
19. Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy (PDR)
20. Synthesis pattern of matrix metalloproteinases (MMPS) and inhibitors (TIMPS) in human explant organ cultures after treatment with latanoprost and dexamethasone
21. Matrix-metalloproteinase-2 and tissue inhibitors of metalloproteinase-1 in the retinal pigment epithelium and interphotoreceptor matrix: Vectorial secretion and regulation
22. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium
23. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes
24. Expression and tissue localization of membrane-type 1, 2 and 3 matrix metalloproteinases in human astrocytic tumors
25. Cytokines in proliferative vitreoretinopathy
26. Cytokines in human intra-ocular inflammation
27. Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy
28. Distribution of TNFα and vascular adhesion molecules in fibrocellular membranes of proliferative diabetic retinopathy
29. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF and IL-1 beta through prostaglandin-dependent and independent mechanisms
30. TNF-alpha-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts
31. + T lymphocytes to the glycoprotein
32. Tumour necrosis factor-alpha interacts with laminin and functions as a pro-adhesive cytokine
33. TNF-alpha associated with extracellular matrix fibronectin provides a stop signal for chemotactically migrating T cells
34. Proteins of the extracellular matrix in vitreoretinal membranes
35. Fibronectin-bound TNF-alpha stimulates monocyte matrix metalloproteinase-9 expression and regulates chemotaxis
36. Establishment and characterization of a retinal Muller cell line
37. Spontaneously immortalized human Müller cell line (MIO-M1) retains the characteristics of primary cells in vitro
38. Cultured Muller cells have high levels of epidermal growth factor receptors
39. Non-radioisotopic quantitative RT-PCR to detect changes in mRNA levels during early mouse embryo development
40. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes
41. Matrix metalloproteinase 2 activation modulates glioma cell migration
42. Airway epithelial cell migration dynamics. MMP-9 role in cell-extracellular matrix remodelling
43. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases
44. Mechanisms for pro matrix metalloproteinase activation
45. Localization of TIMP-3 mRNA expression to the retinal pigment epithelium
46. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes
47. TGB-β increases retinal endothelial cell permeability by increasing MMP-9: Possible role of glial cells in endothelial barrier function
48. Extracellular matrix remodelling and cellular differentiation
49. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signalling pathways
50. Fibronectin-cell mediated cell adhesion is required for induction of 92-kDa type IV collagenase/gelatinase (MMP-9) gene expression during macrophage differentiation
51. MMP-9 from TNFα-stimulated keratinocytes binds to cell membranes and type 1 collagen: A cause for extended matrix degradation in inflammation?
52. Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells
53. Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts
54. Characterization of an endogenous metalloproteinase in human vitreous
55. Differential expression of matrix metalloproteinases in normal and chronically detached retina
56. Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: Correlations with demyelinating activity and oligodendrocyte pathology
57. Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer's disease patients
58. AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines
59. Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia
60. Matrix metalloproteinases and diseases of the CNS